RECRUITINGINTERVENTIONAL
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
About This Trial
The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age 12-21 years old
- Any sickle cell disease genotype
- On steady state of hydroxyurea for 2 months
- Own of have access to a smartphone during the study period
Who Should NOT Join This Trial:
- Recent hospitalizations within the past 7 days
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age 12-21 years old
* Any sickle cell disease genotype
* On steady state of hydroxyurea for 2 months
* Own of have access to a smartphone during the study period
Exclusion Criteria:
* Recent hospitalizations within the past 7 days
Treatments Being Tested
BEHAVIORAL
MED-Go App
A novel multifunctional mobile app (MED-Go) to improve adherence to hydroxyurea in patients with sickle cell disease
Locations (1)
Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, United States